Outbreak News

The Ministry of Health & Population has released Frequently Asked Questions (FAQs) on the COVID-19 vaccine. The COVID-19 vaccination campaign will be launched from Jan 27, 2021 in Nepal.

The Department of Drug Administration (DDA) has decided to approve ‘COVISHIELD’ COVID-19 vaccine for emergency use in Nepal. DDA provided the conditional permission for emergency authorisation of COVISHEILD vaccine against …

WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access. The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine …

COVAX Advance Market Commitment (AMC)-Eligible economies. The 92 low- and middle-income economies are eligible to have their participation in the COVAX Facility supported by the COVAX AMC. What is COVAX? …

COVAX is a bold international initiative to ensure fair and equitable access to COVID-19 vaccines for all countries regardless of wealth. The COVAX Facility (Facility) is responsible for securing the …

WHAT IS COVAX? COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator COVAX is one of three pillars of the Access to COVID-19 Tools (ACT) Accelerator, …

List of Laboratories for SARS CoV-2 Rapid Antigen Test S.No. Lab/Hospital Registration Number Lab name, Address Lab focal person Kit name, Manufacturer company Listed Date 1 3A-00013 Alfa Health Careand …

The Ministry of Health & Population endorsed a guideline for Guideline for COVID19 Facilitation Group Mobilization.

The Ministry of Health & Population endorsed a guideline for Isolation Kit distribution. This guideline provides a guidance to local government to reduce the risk at home isolation.

Update: 20 November 2020 WHO has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that remdesivir …